Armata Pharmaceuticals Inc

Healthcare · Biotechnology

3.80$ -1.0% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Armata Pharmaceuticals Inc (ARMP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 90 million $. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

Tick rows to compare them in a chart (up to 4)

Balance Sheet ARMP
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	26	18	14	15	14	11	14	12	11	12	9.6	35	29	25	44	49	46	40	53	48	43	70	108	101	93	96	109	113	113	98	120	108	98	86	87	81	90	77	70	90
Current Assets	4.6	6.4	2.6	9.2	8.0	5.4	8.7	6.1	5.1	8.4	5.9	14	9.9	6.7	26	21	17	11	24	20	14	15	49	41	33	27	39	37	37	19	42	31	22	11	13	7.5	17	11	5.9	27
Cash	4.0	5.7	2.2	9.0	7.7	5.1	8.2	5.8	4.5	8.2	5.5	13	8.7	6.0	24	20	16	9.6	22	18	12	10	46	37	25	15	25	24	24	14	38	26	17	9.3	12	4.3	15	8.7	4.8	24
Cash & Short-Term Investments	4.0	5.7	2.2	9.0	7.7	5.1	8.2	5.8	4.5	8.2	5.5	13	8.7	6.0	24	20	16	9.6	22	18	12	10	46	37	25	15	25	24	24	14	38	26	17	9.3	12	4.3	15	8.7	4.8	24
Receivables	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	1.0	–	0.3	0.6	1.1	1.2	1.3	3.0	1.2	1.9	1.9	8.5	1.3	8.5	8.5	3.4	1.7	1.2	2.2	0.7	0.2	2.2	0.8	0.5	0.0	2.5
Inventory	–	-0.6	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-1.7	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	0.5	0.7	6.1	4.8	4.2	3.8	13	13	13	2.1	13	13	2.2	2.2	3.3	4.3	3.6	5.4	8.8	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	7.6	–	–	–	–	–	–	–	–	–	–	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5	3.5
Intangible Assets	13	11	11	5.0	4.9	4.9	4.9	4.9	4.9	3.0	3.0	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10	10
Total Liabilities	7.8	8.5	7.7	5.2	4.0	3.4	3.1	3.4	3.8	3.4	4.7	12	11	11	11	20	21	21	19	20	19	44	46	48	47	60	86	125	125	130	177	154	149	134	141	150	185	295	381	321
Current Liabilities	3.2	3.6	2.9	3.7	2.5	2.0	1.8	2.0	2.5	2.6	3.6	5.6	5.0	4.9	6.4	5.2	7.1	6.7	5.0	5.9	5.3	4.8	6.2	7.4	7.0	25	51	22	22	16	110	123	118	48	111	120	140	8.9	9.2	250
Short-Term Debt	–	0.8	0.6	0.6	0.3	–	–	–	–	–	1.1	1.3	1.3	1.3	1.4	1.1	2.1	2.3	2.3	2.4	1.7	1.5	1.5	1.7	2.2	17	45	13	13	9.5	104	118	112	43	107	117	136	4.6	4.6	246
Accounts Payable	2.2	1.1	1.1	1.9	0.9	0.6	0.8	0.7	0.7	0.7	0.2	1.8	1.3	1.3	1.4	1.5	1.9	1.0	1.8	2.3	1.8	1.1	3.4	4.0	3.0	1.7	5.0	3.8	3.8	1.6	2.1	1.7	1.8	0.8	1.0	1.0	1.3	0.9	0.7	1.2
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	2.6	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	72	82	35	–	–	55	–	–	15	257	343	–
Shareholders' Equity	18	9.7	6.6	9.9	9.8	7.7	11	8.3	6.9	8.5	5.0	23	18	15	33	30	25	19	34	29	24	25	62	53	46	36	22	-12	-12	-32	-57	-46	-51	-48	-54	-70	-96	-219	-312	-231
Retained Earnings	-372	-381	-385	-391	-392	-394	-397	-400	-402	-406	-410	-146	-153	-158	-163	-167	-173	-180	-185	-191	-197	-203	-212	-221	-229	-240	-254	-289	-289	-309	-334	-325	-330	-328	-334	-351	-377	-502	-617	-543
Shares Outstanding	0.1	0.1	0.1	0.4	0.6	0.7	0.9	0.3	0.3	0.3	0.3	7.7	9.6	9.6	10	18	18	18	20	25	25	26	29	36	36	36	36	36	36	36	36	58	36	59	36	36	36	36	37	62

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings